Short communication: The effect of heat treatment of bovine colostrum on the concentration of oligosaccharides in colostrum and in the intestine of neonatal male Holstein calves.

The objective of this study was to determine the effect of the heat treatment (HT, 60°C for 60 min) on the concentration of bovine colostrum oligosaccharides (bCO) in pooled bovine colostrum and the intestine of neonatal male Holstein calves after feeding. First-milking colostrum was pooled from both primiparous and multiparous cows, and half of the pooled colostrum was heat-treated at 60°C for 60 min (HC), whereas the other half was not heat-treated and remained fresh (FC). At birth, 32 male Holstein calves were randomly assigned to 1 of 3 treatment groups: (1) control calves that did not receive colostrum for the duration of the experiment and were euthanized at 6 h (NC, n = 4) or 12 h (NC, n = 4), (2) calves fed fresh colostrum (FC) and were euthanized at 6 h (FC, n = 6) or 12 h (FC, n = 6), or (3) calves fed heat-treated colostrum (HC) and euthanized at 6 h (HC, n = 6) or 12 h (HC, n = 6). All calves were fed 2 L of colostrum within 1 h after birth. At dissection, digesta of the distal jejunum, ileum, and colon was collected and analyzed by liquid chromatography-mass spectrometry to determine the concentration of bCO within each intestinal region. The heat-treated colostrum displayed numerically higher concentrations of total bCO (3,511.6 µg/g) when compared with fresh colostrum (1,329.9 µg/g), with 3'-sialyllactose being the most abundant bCO in both fresh and HT colostrum. In contrast, calves fed HT colostrum displayed a lower amount of total bCO in the distal jejunum (221.91 ± 105.3 vs. 611.26 ± 265.1 µg/g), ileum (64.97 ± 48.39 vs. 344.04 ± 216.87 µg/g), and colon (25.60 ± 13.1 vs. 267.04 ± 125.81 µg/g) at 6 h of life when compared with calves fed fresh colostrum. No differences were observed in regard to the concentrations of total bCO in the intestine of FC and HC calves at 12 h of life. It is speculated that lower concentrations of bCO in the gastrointestinal tract of HC calves at 6 h of life could be due to the early establishment of beneficial bacteria, such as Bifidobacterium, in HC calves and their subsequent metabolism of bCO as a carbon source. These findings suggest that the heat treatment of colostrum increases the amount of free bCO, which may serve as prebiotics available to microbiota within the intestine of the neonatal calf.

Doxorubicin-Induced Gut Toxicity in Piglets Fed Bovine Milk and Colostrum.

OBJECTIVE: Chemotherapy-induced intestinal toxicity is a common adverse effect of cancer treatment. We hypothesized that a milk diet containing bovine colostrum (BC) would reduce intestinal toxicity in doxorubicin-treated piglets. METHODS: "Study 1" investigated intestinal parameters 9 days after a single dose of doxorubicin (1 × 75 mg/m) in piglets fed bovine milk enriched with whey protein (BM). In "study 2," responses to doxorubicin treatment were investigated in piglets receiving either 7 BC feedings per day (Only-BC, n = 13), 4 BC feedings (High-BC, n = 13), 2 BC feedings (Low-BC, n = 14), or no BC (only BM, n = 13). RESULTS: Doxorubicin treatment induced clinical signs of intestinal toxicity with diarrhea and weight loss, relative to controls (P < 0.05). White blood cells, hexose absorptive function, plasma citrulline, weights of intestine, colon, and spleen were reduced, whereas gut permeability and plasma C-reactive protein levels were increased (all P < 0.05). Limited or no effects were observed for digestive enzymes, proinflammatory cytokines, or tight-junction proteins in the intestine. Increasing BC supplementation to doxorubicin-treated piglets (study 2) had no consistent effects on plasma C-reactive protein and citrulline levels, intestinal morphology, digestive enzymes, permeability, or proinflammatory cytokines. Only-BC pigs, however, had lower diarrhea severity toward the end of the experiment (P < 0.05 vs BM) and across the BC groups, intestinal toxicity was reduced (P < 0.01). CONCLUSIONS: Doxorubicin-treated piglets are relevant for studying chemotherapy-induced gut toxicity. Colostrum supplementation had limited effects on doxorubicin-induced toxicity in milk-fed piglets suggesting that colostrum and a bovine milk diet enriched with whey protein provided similar protection of the developing intestine from chemotherapy-induced toxicity.

Prepartum supplementation of nicotinic acid: Effects on health of the dam, colostrum quality, and acquisition of immunity in the calf.

Nicotinic acid (NA) has been shown to reduce lipolysis, alter milk components and the ruminal environment, and increase blood flow. Increased blood flow to the mammary gland during colostrogenesis might increase nutrients and immunoglobulin concentration of colostrum. Twenty-six multiparous Holstein cows were housed in a tiestall barn. Cows were blocked by expected calving date and randomly assigned to 1 of 2 treatments 4 wk prepartum: (1) 0g/d of NA (control, CON) or (2) 48g/d of NA (NA). Total mixed ration amounts fed and refused were measured daily to determine dry matter intake. Blood samples were collected from dams every Monday, Wednesday, and Friday from the coccygeal vein or artery and were analyzed for glucose, nonesterified fatty acids (NEFA), and ß-hydroxybutyrate (BHB). Colostrum was collected and weighed within 90 min of parturition. Colostral immunoglobulin G (IgG) concentration was analyzed using radial immunodiffusion assay. Calves were removed from their dams before suckling and weighed within 30 min after birth. Calves received 3 L of a lacteal-based colostrum replacer that provided a total of 225.8g of IgG within 2h of birth. Calf blood samples were collected via jugular venipuncture at 0 and 24h of age and analyzed for IgG concentration and determination of apparent efficiency of absorption. Colostrum yield, dry matter intake, IgG yield, and fat and solids percentage of colostrum did not differ between treatments. Serum concentrations of glucose and BHB were not affected by treatment. We detected an effect of week on serum glucose concentrations at calving and on serum BHB concentrations at 1 wk postpartum. There was a treatment by week effect for serum NEFA concentrations at 1 wk postpartum, where cows that received NA prepartum had higher serum NEFA concentration than CON cows, indicating that a NEFA rebound occurred. No differences were observed for calf body weight, 0- or 24-h serum IgG concentration, or apparent efficiency of absorption. Supplementation of NA increased IgG concentration in colostrum from 73.8 to 86.8g/L. Results indicate that 48g/d of supplemental NA during the prepartum period improved colostrum quality.

Sodium dodecyl sulfate reduces bacterial contamination in goat colostrum without negative effects on immune passive transfer in goat kids.

To investigate the use of sodium dodecyl sulfate (SDS) as a biocide on goat colostrum, 2 experiments were performed. In the first, 20 goat colostrum samples were divided into 3 aliquots. A different treatment was performed on each aliquot: pasteurization (56°C, 30 min) or addition of SDS to a final concentration of either 0.1 or 1% (36°C, 10 min). Immunoglobulin G and colony-forming units were evaluated before and after treatment. Both pasteurization and treatment with 1% SDS significantly reduced the colony-forming units in colostrum. Treatment with 0.1% SDS was not effective at reducing the colony-forming units in colostrum. The IgG concentration of pasteurized colostrum was significantly lower than that of untreated colostrum, whereas treatment with 1% SDS did not affect the colostrum IgG concentration. In the second experiment, the effects of SDS colostrum treatment on immune passive transfer were evaluated. Forty goat kids were fed either refrigerated colostrum or colostrum treated with 1% SDS twice daily for 2 d. Blood samples were obtained at birth and every day for 5 d. IgG, IgM, and IgA were measured in blood serum to monitor the passive immune transfer process. Creatinine, glucose, total cholesterol, blood urea nitrogen, bilirubin, and aspartate transaminase were also monitored to evaluate the health of kids. No differences in serum IgG, IgM, IgA, creatinine, glucose, total cholesterol, blood urea nitrogen, bilirubin, or aspartate transaminase levels were observed between groups. Our findings indicate that SDS is an efficient colostrum biocide that, unlike pasteurization, does not affect immune passive transfer or goat kid health.

Long-term chromium picolinate supplementation improves colostrum profile of Santa Ines ewe.

Chromium (Cr) is a micromineral that is involved in the metabolism of carbohydrates, lipids, ammonia, and nucleic acids; thus, its supplementation can influence the nutritional status of ruminants, and consequently, colostrum profile, since this secretion depends on products secreted by the mammary gland and elements of the maternal bloodstream. The present study investigated the influence of supplementation with Cr bound to organic molecule on the nutritional, immune, and antioxidant quality of ewe colostrum. Thirty-two multiparous Santa Ines ewes (55.3 ± 8.00 kg body weight) were randomly assigned into four groups: T1 (0.0 mg of chromium picolinate (CrPic) supplementation per ewe, n = 8), T2 (0.15 mg of CrPic per ewe, n = 9), T3 (0.30 mg of CrPic per ewe, n = 7), and T4 (0.45 mg of CrPic per ewe, n = 8). Supplementation was supplied during the breeding season, pregnancy, and lactation. Shortly after calving, the first milking colostrum was collected to determine its chemical composition, activity of lysozyme, lactoperoxidase, ceruloplasmin, catalase, glutathione peroxidase, and oxygen radical absorbance capacity. The results show that lactoperoxidase activity decreased with CrPic supplementation (P < 0.01), revealing that this micromineral reduces an important component of defense mechanism in the body. Therefore, the results of this work show that supplementation with chromium picolinate influences colostrum quality.

Administration of carbetocin after the first piglet was born reduced farrowing duration but compromised colostrum intake in newborn piglets.

Carbetocin is an oxytocin-like compound with long acting properties that has recently been introduced to both human and domestic animal obstetrics. The aims of the present study were to evaluate the effects of carbetocin administration after the first piglet was born on farrowing duration, birth interval, colostrum consumption and vitality index in newborn piglets. In total, 186 sows and their offspring (n = 2611 piglets) were distributed into three groups: 1) CONTROL: sows were allowed to farrow naturally (n = 66); 2) OXY: sows were administered oxytocin 20 IU intramuscularly after the first piglet was born (n = 62); and 3) CARBE: sows were administered carbetocin 0.6 µg/kg intramuscularly after the first piglet was born (n = 58). The reproductive data of sows including farrowing duration, total number of piglets born per litter (TB), number of piglets born alive per litter (BA), proportion of stillborn piglets per litter (SB) and proportion of mummified fetuses per litter (MF) were recorded. Piglet vitality index including skin colour, integrity of the umbilical cord, heart rate, blood oxygen saturation, screaming score, udder stimulation score, movement capacity and number of completed circles around enclosure were determined. Birth weights of the piglets were measured immediately at birth and again at 24 h thereafter to determine the individual colostrum intake of the piglets. On average, the farrowing duration, birth interval and BA were 188.0 ±â€¯95.7 min, 12.5 ±â€¯18.3 min, and 12.3 ±â€¯2.9 piglets per litter, respectively. The farrowing duration of the sows was reduced in CARBE group (151.2 ±â€¯11.9 min) compared to OXY (180.2 ±â€¯11.5 min, P = 0.003) and CONTROL (227.7 ±â€¯11.2 min, P < 0.001) groups. Birth interval of piglets in all categories of birth weight in the CARBE group was shorter than those in the CONTROL group (P < 0.05). However, the colostrum yield of sows in CARBE group (2398 ±â€¯133 g) was lower than CONTROL and OXY groups (3371 ±â€¯125 g and 3549 ±â€¯128 g, respectively; P < 0.001). Similarly, colostrum intake of piglets in the CONTROL and OXY groups was higher than in the CARBE group (276.4 ±â€¯11.0 g, 286.4 ±â€¯13.6 g and 225.3 ±â€¯14.0 g, respectively; P < 0.05). The percentage of stillborn piglets in CARBE was higher than OXY (8.7 ±â€¯1.1% vs 5.3 ±â€¯1.1%, P < 0.05) but did not differ significantly compared to CONTROL (7.5 ±â€¯1.1%, P > 0.05). The piglet movement capacity in CONTROL was lower than CARBE group (1.36 vs 1.48, P < 0.05) but was not different compared to OXY group (1.40, P > 0.05). In conclusion, administration of carbetocin after the birth of the first piglet reduced the farrowing duration of sows, but increased the number of stillborn piglets and reduced the colostrum yield of sows.

Obesity as an Inflammatory Agent Can Cause Cellular Changes in Human Milk due to the Actions of the Adipokines Leptin and Adiponectin.

Adiponectin and leptin play roles in the hunger response, and they can induce the inflammatory process as the initial mechanism of the innate immune response. It is possible for alterations in the levels of these adipokines to compromise the functional activity of human colostrum phagocytes. Therefore, the objective of this study is to analyze the effects of adiponectin and leptin on colostrum mononuclear (MN) cells. Colostrum was collected from 80 healthy donors, who were divided into two groups: the control group and the high body mass index (BMI) group. MN cells were used to analyze phagocytosis by flow cytometry, and reactive oxygen species (ROS), intracellular calcium, and apoptosis were assessed by fluorimetry using a microplate reader. Adipokines restored the levels of phagocytosis to the high BMI group (p < 0.05), with a mechanism that is action-dependent on the release of ROS and intracellular calcium. However, adiponectin and leptin simultaneously contributed to better microbicidal activity, thus reflecting an increase in the apoptosis level (p < 0.05) in the high BMI group. Probably, the maintenance of the balance between adiponectin and leptin levels enhances the protection and decreases the indices of neonatal infection in the breastfeeding infants of women with high BMI values. Therefore, policies that support pre-gestational weight control should be encouraged.

Increasing selenium supply for heat-stressed or actively cooled sows improves piglet preweaning survival, colostrum and milk composition, as well as maternal selenium, antioxidant status and immunoglobulin transfer.

This study aimed to evaluate the effects of increasing selenium (Se) supply for heat-stressed or actively cooled sows on sow productivity, colostrum and milk composition, as well as the selenium and antioxidant status and immunoglobulin levels of sows and nursing piglets. The study was a 2 × 2 factorial design, where the first factor was farrowing environment [heat stress vs. actively cooling, temperature: 29.61 ± 0.19 ℃ (27.70-31.60 ℃) vs. 27.90 ± 0.15 ℃ (26.90-30.20 ℃); temperature-humidity index: 72.91 ± 0.26 (70.30-75.70) vs. 70.81 ± 0.22 (69.30-73.80)], and the second factor was dietary Se level during late gestation and lactation [(0.3 vs. 1.2 mg/kg Se as Se-yeast, the basal diet was corn-soybean meal diet formulated according to NRC (2012) except for Se level]. Forty multiparous sows (Landrace × Yorkshire) were randomly allotted to 1 of 4 treatments (10 sows and following 90 piglets per treatment, respectively). The results show that: (1) There were no interactions of farrowing environment with Se treatments with the exceptions of nutrient content of 7-d milk; (2) As for zootechnical measures, piglets of sows receiving increasing Se tended to have greater preweaning survival compared with those of sows receiving control diet without interactions of environment and Se treatments; (3) As to colostrum and milk composition, greater concentrations of protein, lactose, solids-not-fat in colostrum, and greater fat concentration in 7-d and 14-d milk were found for sows fed increasing Se; (4) Regarding Se and antioxidant status, increasing Se supply for sows increased Se content in colostrum and 21-d milk, as well as in plasma of 1-day-old and 21-day-old piglets. Meanwhile, increasing Se supply for sows improved antioxidant status in colostrum (MDA content) and 21-d milk (T-AOC and MDA content), as well as in plasma of 1-day-old and 21-day-old piglets (GSH-Px activity and MDA content); (5) With regard to immunoglobulins, sows fed increasing Se had higher IgM levels in colostrum, and higher IgA in 21-d milk. Also, piglets from sows fed increasing Se had higher plasma IgA at 1 d of age, and higher IgA and IgG levels at 21 d of age. Collectively, increasing selenium supply for heat-stressed or actively cooled sows improved piglet preweaning survival, colostrum and milk composition, as well as maternal selenium, antioxidant status and immunoglobulin transfer irrespective of the climatic conditions, which indicates that Se requirements for sows should be urgently reassessed.

Prepartum fatty acid supplementation in sheep. II. Supplementation of eicosapentaenoic acid and docosahexaenoic acid during late gestation alters the fatty acid profile of plasma, colostrum, milk and adipose tissue, and increases lipogenic gene expression of adipose tissue.

The objectives of this study were as follows: 1) to establish whether feeding a source of eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA) to ewes during late gestation changes the fatty acid profile of colostrum, milk, ewe adipose tissue, and plasma and subsequently lamb plasma and red blood cells (RBC), and 2) to investigate the effects of EPA and DHA on mRNA expression in ewe adipose tissue. Eighty-four gestating ewes (28 pens, three per pen) were blocked by lambing day and assigned to a diet with an addition of fat at 0.39% of the DM during the last 50 d of gestation using Ca salts of a palm fatty acid distillate (PFAD) high in palmitic and oleic acids or EPA + DHA. Blood samples were taken from ewes on days 20, 1 (parturition), and 30 and from lambs on days 1 and 30 for plasma fatty acid analysis. Fatty analysis of lamb RBC was performed on day 1. Colostrum samples were taken at lambing and milk samples on day 30 for fatty acid analysis. Subcutaneous adipose tissue biopsies were taken from one ewe per pen on day 20 for fatty acid analysis and gene expression analysis of 27 genes. Treatment × day interactions (P < 0.10) were observed for several isomers of C18:1, with concentrations that were greater in plasma of EPA + DHA ewes on day 20, but were not different on day 1 or 30. Plasma concentrations of EPA tended to be greater (P = 0.07), whereas DHA was greater (P < 0.001) in EPA + DHA ewes compared with PFAD ewes. There was no difference in EPA or DHA in adipose tissue with EPA + DHA vs. PFAD supplementation (P > 0.10). Concentrations of fatty acids with 6 to 10 carbons were significantly increased (P < 0.05) in colostrum and milk of EPA + DHA ewes. There was a treatment × day interaction with EPA + DHA ewes yielding greater EPA (P = 0.03) and DHA (P = 0.04) concentrations than PFAD in colostrum, but not in milk. Treatment × day interactions (P < 0.05) were observed for several C18:1 isomers with concentrations that were greater in EPA + DHA ewe colostrum, but were not different between treatments in milk. In lamb plasma and RBC, EPA and DHA were not different between treatments (P > 0.10). The expression of fatty acid synthase and leptin was significantly increased (P < 0.05), whereas the expression of diacylglycerol acyltransferase 2 tended to be increased (P = 0.08) by supplementation of EPA + DHA vs. PFAD. These results suggest that supplementation with EPA and DHA to ewes during late gestation alters the fatty acid profile of plasma, colostrum, and milk and may increase lipogenesis.

Effect of cobalt supplementation during late gestation and early lactation on milk and serum measures.

Thirty-six multiparous cows were assigned to a study to determine the effects of dietary Co supplementation during late gestation and early lactation on concentrations of Co in serum and liver, vitamin B12 concentrations in serum and milk, and milk yield. Nonlactating cows received diets containing 0.15, 0.89, or 1.71 mg/ kg of Co (dry matter basis) from 55 d before parturition, and lactating cows received diets containing 0.19, 0.57, or 0.93 mg/kg of Co (dry matter basis) from parturition through 120 d postpartum. Serum vitamin B12 concentrations declined sharply in all cows between 55 and 20 d prepartum. Dietary Co supplementation tended to cause an increase in the concentration of vitamin B12 in colostrum and milk. Cobalt intake did not affect concentrations of Co in liver or serum, but increased the Co concentration of milk (0.089, 0.120, and 0.130 microg of Co/mL) at 120 days in milk. There was no effect of Co supplementation on dry matter intake or yield of milk and milk components. In conclusion, serum concentrations of vitamin B12 are reduced in the early dry period, and added dietary Co may increase ruminal synthesis of vitamin B12 as indicated by a tendency for increased vitamin B12 concentrations in colostrum and milk of cows supplemented with dietary Co.

Transfer of Everolimus into Colostrum of a Kidney Transplant Mother.

BACKGROUND Transplanted women are increasingly expressing their desire to breast-feed. Due to the unknown effects that might occur in newborns of everolimus-treated mothers, it is now recommended to inhibit lactation. This report discusses the assessment of everolimus levels in maternal, umbilical, and neonatal blood, and colostrum of a kidney transplant mother. CASE REPORT A 28-year-old white primipara after second kidney transplant, treated with everolimus, conceived unintentionally. Due to the high risk of recurrence of primary disease, the immunosuppressive treatment remained unchanged. At 37 weeks of gestation, due to mild preeclampsia, the woman was qualified for induction of labor and vaginally delivered a healthy infant. The highest concentration of everolimus in the colostrum was observed 4 h after drug administration and was 0.066 ng/ml. The estimated maximal dose of everolimus in colostrum was 0.38% of the mother's dose. CONCLUSIONS Breast-feeding in transplanted women treated with everolimus seems possible, particularly in mothers who are willing to breast-feed, especially in the first days after labor, when levels of immunoglobulins in colostrum are high and the concentrations of everolimus are low.

Mannan oligosaccharide prepartum supplementation: effects on dairy cow colostrum quality and quantity.

Providing the neonatal calf with a sufficient quantity and quality of colostrum may optimise future health, performance and reduce the risk of morbidity. A 6-month double blind trial with 80 prepartum dairy cows was conducted to determine if supplementation with mannan oligosaccharide (MOS) influences colostrum quality, quantity and subsequent calf performance. The Holstein cross Friesian 80 cows (no heifers) were allocated into a control and treatment group at the point of drying off by previous lactation number and yield. The control and treatment group were fed the same commercial standard dry cow diet throughout the trial supplemented with a mineral concentrate without or with 1.33% MOS, respectively. Cows were milked out of colostrum within 40 min of calving prior to calf suckling, weight was recorded. Mannan oligosaccharide fed cows produced significantly more colostrum on first milking (7.5 kg, SEM±0.69) compared with cows fed without MOS (5.6 kg, SEM±0.43). The immunoglobulin G (IgG) concentrations (control 53.7 IgG g/l, SEM±5.8 and MOS of 42.7 IgG g/l, SEM±4.9) and total mass of IgG did not differ between treatments. No significant observable MOS-derived effect on calf health or weight gain occurred during the study.

Effects of sodium butyrate supplementation on reproductive performance and colostrum composition in gilts.

Nutrients are essential for the health and survival of human beings and animals. Also, they play a major role in enhancing reproductive efficiency. The aim of the current study was to investigate the effects of sodium butyrate (SB) on reproductive performance and colostrum composition in gilts. A total of 40 Large White×Landrace replacement gilts (at the age of 160 to 175 days) were fed either a standard diet (control group, n=20) or standard diet top dressed with encapsulated SB at the level of 500 mg/kg (SB group, n=20) from 1 month before mating to 7 days after farrowing. The rate of gilts regular return to estrus after insemination was lower in SB group than the control group. The total number of piglets born (P=0.179) and the litter weight at birth (P=0.063) did not differ between the two treatment groups. However, the mean BW at day 7 tended to be greater in SB group (P=0.051) and average daily gain of piglets was greater (P=0.011) compared with control group. Colostrum samples were collected at parturition and the concentrations of total protein (P=0.197), cholesterol (P=0.161) and lactose (P=0.923) were not influenced by SB supplementation. However, compared with control gilts, colostrum from SB-treated gilts contained lower triglyceride (P=0.050). Moreover, colostrum concentrations of prolactin (P=0.005) and leptin (P=0.006) were significantly lower in SB group. No significant differences were noted for the colostral concentrations of cortisol (P=0.899), thyroxine (P=0.891) or triiodothyronine (P=0.194). The concentration of lipopolysaccharide in colostrum was not influenced by SB supplementation (P=0.972). However, colostrum from SB-treated gilts had significantly lower tumor necrosis factor α (TNFα) (P=0.030) and higher immunoglobulin A (IgA) (P=0.042). Collectively, SB supplementation could reduce the rate of gilts return to estrus, alter the composition of colostrum and enhance the growth rate of piglets. Moreover, SB could alter the immune function of newborn piglets through decreased production of TNFα and increased IgA concentration in colostrum.

Effect of maternal vitamin A supplementation on retinol concentration in colostrum.

OBJECTIVE: To investigate the effect of vitamin A supplementation on the retinol concentration in colostrum under fasting and postprandial conditions. METHODS: This was a quasi-experimental study, with before and after assessments, conducted with 33 patients treated at a public maternity hospital. Blood and colostrum samples were collected under fasting conditions in the immediate postpartum period. A second colostrum collection occurred two hours after the first meal of the day, at which time a mega dose of 200,000 IU of retinyl palmitate was administered. On the following day, the colostrum was collected again under fasting and postprandial conditions. Serum and colostrum retinol concentrations were determined by high performance liquid chromatography. RESULTS: The serum retinol concentration was 37.3 (16.8-62.2) µg/dL, indicating adequate nutritional status. The colostrum retinol concentration before supplementation was 46.8 (29.7-158.9) µg/dL in fasting and 67.3 (31.1-148.7) µg/dL in postprandial condition (p < 0.05), showing an increase of 43.8%. After supplementation, the values were 89.5 (32.9-264.2) µg/dL and 102.7 (37.3-378.3) µg/dL in fasting and postprandial conditions, respectively (p < 0.05), representing an increase of 14.7%. CONCLUSIONS: This study demonstrated that maternal supplementation with high doses of vitamin A in postpartum resulted in a significant increase of the retinol concentration in colostrum under fasting conditions, with an even greater increase after a meal.

Nanoparticles of barium induce apoptosis in human phagocytes.

PURPOSE: Nutrients and immunological factors of breast milk are essential for newborn growth and the development of their immune system, but this secretion can contain organic and inorganic toxins such as barium. Colostrum contamination with barium is an important issue to investigate because this naturally occurring element is also associated with human activity and industrial pollution. The study evaluated the administration of barium nanoparticles to colostrum, assessing the viability and functional activity of colostral mononuclear phagocytes. METHODS: Colostrum was collected from 24 clinically healthy women (aged 18-35 years). Cell viability, superoxide release, intracellular Ca(2+) release, and phagocyte apoptosis were analyzed in the samples. RESULTS: Treatment with barium lowered mononuclear phagocyte viability, increased superoxide release, and reduced intracellular calcium release. In addition, barium increased cell death by apoptosis. CONCLUSION: These data suggest that nanoparticles of barium in colostrum are toxic to cells, showing the importance of avoiding exposure to this element.

Influence of body condition and lasalocid during late gestation on blood metabolites, lamb birth weight and colostrum composition and production in Finn-cross ewes.

The objective of this experiment was to examine the effects of body condition (BC) and of lasalocid (L) the last 4 wk of gestation on blood metabolite profiles, lamb birth weight and colostrum composition and production. Twenty-eight 3-yr-old Finn-Targhee ewes (73 kg) were assigned randomly within BC grouping (2.5 or 3.5) and individually fed a diet of 90% alfalfa pellets and 10% of a supplement containing either no L (C = control) or L. Gestation and 24-h postlambing weights were higher (P less than .05) for 3.5 BC versus 2.5 BC ewes. Lasalocid had no effect (P greater than .05) on ewe weight. Average number of lambs born within treatment groups were similar (P greater than .05). Total kilograms of lamb born were greater (P less than .10) for 3.5 BC ewes. Body condition 3.5 ewes had greater concentrations of total protein (P less than .10) and albumin (P less than .05) the last 4 wk of gestation than those in the 2.5 BC group. Feeding L decreased (P less than .05) blood urea-N in comparison with C ewes. Colostrum composition and production were not influenced (P greater than .05) by BC, L or number of lambs born. Serum 3-hydroxybutyrate seemed to be a good indicator of energy metabolism; albumin and blood urea-N concentrations reflected dietary protein intake. Lasalocid had a minimal effect on nutrient metabolism and productivity of ewes fed in excess of the NRC (1985) protein and energy requirements.

Effects of vitamin E and selenium on immune responses of peripheral blood, colostrum, and milk leukocytes of sows.

This study was designed to assess how dietary vitamin E (E) and (or) selenium (Se) concentrations affect immune responses of gestating and peripartum sows. Multiparous sows (24), assigned to one of four groups at breeding, were fed ensiled, shelled corn-soybean meal-based diets without supplemental E or Se (-E-Se), with .3 mg of Se/kg (-E+Se), with 60 IU of E/kg (+E-Se), or with both supplemental E and Se (+E+Se) during gestation and to d 4 of lactation. Blood was obtained on 0, 30, 60, and 90 d of gestation and at parturition for serum E and Se assays. Lymphocytes and polymorphonuclear cells (PMN) were isolated from the blood, colostrum, and 4-d milk samples for immune studies. Compared with the control (+E+Se) diet, the -E-Se diet reduced (P < .05) the serum tocopherol and Se concentrations, the mitogenic responses of lymphocytes of peripheral blood (PBL) and colostrum (CL), the phagocytic activity of blood and colostral PMN, and the microbicidal activity of blood, colostral, and milk PMN. The -E+Se diet reduced (P < .05) the serum tocopherol concentrations, the mitogenic responses of PBL and CL, and the phagocytic activity of PBL. The +E-Se diet reduced (P < .05) serum Se concentrations and the phagocytic activity of PMN. The data indicated that E restriction depressed PBL and PMN immune functions, whereas Se restriction depressed mainly PMN function.

Effect of level and source of dietary selenium on concentrations of thyroid hormones and immunoglobulins in beef cows and calves.

Our objective was to determine the effect of level and chemical form of dietary selenium on productivity of beef cows, concentrations of triiodothyronine (T3), and thyroxine (T4) in plasma, and immunoglobulins (IgG and IgM) in plasma and colostrum of cows. Pregnant cows (n = 60) were randomly allocated among four dietary treatments of 20, 60, or 120 ppm Se as selenite and 60 ppm as selenomethionine from selenized yeast (SeY) in salts offered free-choice. Treatments began 90 d prepartum and continued through the second parturition. Treatments did not affect the final body weights of cows or birth weights or weaning weights of calves. At parturition, cows given salt with 20 ppm Se as selenite had lower (P < . 05) concentrations of Se in blood than cows with access to higher-Se salts. Treatments affected (P < .01) the concentration of T3 and the ratio of T3:T4 in plasma of cows. The concentration of T3 in plasma of cows with access to salt with 20 ppm Se was 14% lower than that in cows supplemented with 60 ppm Se as selenite or SeY. Plasma IgG in cows and calves, colostrum, and Se concentrations in colostrum, casein, and whey were lowest (P < .01) for cows given salt with only 20 ppm Se. Thus, salts with concentrations of 60 and 120 ppm Se improved measures of Se status in cows and calves. Consideration should be given to the concentrations of T3 and IgG when determining the nutritional requirements for Se in cattle.

Effect of selenium supplementation on colostral IgG concentration in cows grazing selenium-deficient pastures and on postsuckle serum IgG concentration in their calves.

Effects of selenium (Se) deficiency and supplementation on production of colostral immunoglobulins by beef cows and transfer of antigen-specific and nonspecific immunoglobulins to their calves were examined. Eight beef cows, with marginal to deficient Se status (blood Se concentration, 50 micrograms/L), were allotted by breed and age to 1 of 4 Se treatment groups (n = 20/group): no supplemental Se; parenteral administration of 0.1 mg of Se and 1 mg of vitamin E/kg of body weight; ad libitum consumption of 120 mg of Se/kg of salt-mineral mix (SMM); and parenteral administration of 0.1 mg of Se and 1 mg of vitamin E/kg plus ad libitum consumption of 120 mg of Se/kg of SMM. All cows were inoculated IM with lysozyme. Cows consumed Se-deficient pastures or hay (21 to 62 micrograms/kg) during the study that began at mid-gestation and ended at postpartum hour 24. Although the concentration of specific lysozyme antibodies was not affected, cows given 120 mg of Se/kg of SMM (treatments 3 and 4) had higher colostral IgG concentration (P < 0.002) than did Se-deficient cows (treatments 1 and 2). Calves from cows in treatments 3 and 4 had higher postsuckle serum concentrations of IgG (P < 0.01) than did calves from cows in treatments 1 and 2. Colostral IgM and calf serum IgM concentrations did not differ among treatments.

Effects of selenium and vitamin E administration during a late stage of pregnancy on colostrum and milk production in dairy cows, and on passive immunity and growth of their offspring.

OBJECTIVE: To determine effects of selenium (Se) and vitamin E (VE) administration in late pregnancy on Se status, plasma immunoglobulin concentrations, and colostrum and milk production of dairy cows, and on Se status, passive immunity, and growth of their offspring. ANIMALS: 25 Holstein cows and their offspring. PROCEDURE: 3 and 1.5 weeks before calving, sodium selenite (5 mg/100 kg of body weight) and d,l-alpha-tocopheryl acetate (25 IU/100 kg) were administered to 13 cows. The other 12 cows were not treated. Se status was assessed by measurement of glutathione peroxidase activity of erythrocytes (GSH-Px-E). RESULTS: The 13 treated cows had higher (P < 0.01) GSH-Px-E values at calving and during the first 12 weeks of lactation. Changes in plasma immunoglobulin concentrations before or after calving did not differ between the 2 groups of cows. During the first 36 hours after calving (4 milkings), treated cows produced 22% more colostrum than did their nontreated counterparts (P < 0.005). Percentages of colostral immunoglobulins did not differ between the 2 groups. During the first 12 weeks of lactation, treated cows produced 10% more milk than did nontreated cows (P < 0.005). GSH-Px-E values at birth and 28 days of life were significantly higher in calves from treated cows. Plasma immunoglobulin concentrations and body weight during the first 56 days after birth did not differ between calves born to treated or nontreated cows. CONCLUSIONS AND CLINICAL RELEVANCE: Cows given Se and VE in late pregnancy produce large quantities of colostrum and milk. Colostrum produced from cows given Se and VE is suitable to feed newborn calves and to be stored for later use. Improvement of Se status in calves born to cows given Se and VE in late pregnancy is not beneficial to passive immunity and growth.